Caitlin Hogan
banner
cnhogan.bsky.social
Caitlin Hogan
@cnhogan.bsky.social
🌸🩷🫶
More HIV research!! So fun #pitt_26
January 20, 2026 at 8:17 PM
Reposted by Caitlin Hogan
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles

✅ Just Accepted
https://bit.ly/4qAWI6r
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles
This prospective cohort followed 741 people with HIV switching to long-acting intramuscular cabotegravir/rilpivirine. No hepatitis B virus (HBV) incident i
bit.ly
January 18, 2026 at 6:35 PM